Home › Funds › Morgan Stanley › IPA
Morgan Stanley position in IPA
IMMUNOPRECISE ANTIBODIES LTD
Latest position (Q2 2025)10.00K sh
Reported value held$10.60K
Portfolio Weight0.00%
First reportedQ3 2021
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 3.84K | $24.00K | New |
| Q4 2021 | 3.84K | $21.00K | Hold |
| Q1 2022 | 3.84K | $20.00K | Hold |
| Q2 2022 | 1.63K | $6.00K | Reduce |
| Q3 2022 | 533 | $2.00K | Reduce |
| Q4 2022 | 533 | $2.78K | Hold |
| Q1 2023 | 533 | $1.48K | Hold |
| Q2 2023 | 533 | $1.58K | Hold |
| Q3 2023 | 533 | $975 | Hold |
| Q4 2023 | 10.53K | $18.01K | Add |
| Q1 2024 | 10.53K | $16.01K | Hold |
| Q2 2024 | 10.53K | $10.64K | Hold |
| Q3 2024 | 12.53K | $8.01K | Add |
| Q4 2024 | 12.53K | $5.16K | Hold |
| Q1 2025 | 12.53K | $4.72K | Hold |
| Q1 2025 | 12.53K | $4.72K | Hold |
| Q2 2025 | 10.00K | $10.60K | Reduce |
| Q2 2025 | 10.00K | $10.60K | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.